HPV Vaccine Works to Reduce Abnormal Cells in Cohort of Women

After studying the first birth cohort in Denmark to be offered the HPV vaccine, researchers at the Faculty of Health and Medical Sciences at the University of Copenhagen have concluded that the vaccine works to reduce the growth of abnormal cells – known as dysplasia – which could eventually lead to the development of cervical cancer. The study – which was published in the International Journal of Cancer – is the first of its kind to study the impact of the HPV vaccine on the general population.